UPDATE: Auriga Raises PT to $51 on Universal Health Services
Auriga raises its price target on Buy-rated Universal Health Services (NYSE: UHS) to $51 from $45 on in-line Q4 and likely conservative 2012 guidance.
Auriga notes, "UHS issued EPS guidance range to $4.33-$4.48 (v. consensus $4.42) on revenue increase of +5% to $7.24B. Note that revenue guidance includes adoption of ASU No. 2011-7. We believe EPS guidance may prove to be conservative if economic activity continues to improve nationally and picks up in Las Vegas."
UHS closed at $43.97 a share yesterday.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.